Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): A double-blind, placebo-controlled, randomised, phase 3 study

Michael Mannstadt, Bart L. Clarke, Tamara Vokes, Maria Luisa Brandi, Lakshminarayan Ranganath, William D. Fraser, Peter Lakatos, Laszlo Bajnok, Roger Garceau, Leif Mosekilde, Hjalmar Lagast, Dolores Shoback, John P. Bilezikian

Research output: Contribution to journal › Article › peer-review

160 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): A double-blind, placebo-controlled, randomised, phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences